Skip to main content

Table 3 Hazard ratiosa for mortality: multivariate analyses

From: The effect of menopausal hormone therapy on gastrointestinal cancer risk and mortality in South Korea: a population-based cohort study

Outcome variables MHT users Non-users HR 95% CI P
n Rateb n Rateb
All-cause mortality 333 0.238 2173 0.314 0.784 0.698, 0.880 < .0001
Cancer-related mortality 115 0.082 661 0.096 0.874 0.717, 1.066 0.1843
Mortality from GI cancer 50 0.036 338 0.049 0.737 0.547, 0.993 0.0445
 Gastric 7 0.005 86 0.012 0.411 0.190, 0.890 0.0240
 Colorectal 3 0.002 81 0.012 0.181 0.057, 0.572 0.0036
 Hepatobiliary 26 0.019 121 0.018 1.077 0.704, 1.647 0.7332
 Pancreatic 13 0.009 48 0.007 1.333 0.721, 2.463 0.3598
  1. Other covariates (age group, income, region, Charlson comorbidity index, and year of study entry) were adjusted in each survival analysis
  2. CI confidence interval, GI gastrointestinal, HR hazard ratio, MHT menopausal hormone therapy
  3. aAdjusted hazard ratios for mortality in MHT users compared to non-users
  4. bMortality rates per 100,000 person-years